-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, S4dGfS5iS6ys6YR/7D8bf9jWhPJyFAwtucMMzxOn40euMkECf6Z5C3xfHAYjCxKf ZnDOKvFHC3ioxwIU9mmcTQ== 0000947871-99-000118.txt : 19990329 0000947871-99-000118.hdr.sgml : 19990329 ACCESSION NUMBER: 0000947871-99-000118 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19990326 ITEM INFORMATION: FILED AS OF DATE: 19990326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC CENTRAL INDEX KEY: 0001022079 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 161387862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 001-12215 FILM NUMBER: 99573458 BUSINESS ADDRESS: STREET 1: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07608 BUSINESS PHONE: 2013935000 MAIL ADDRESS: STREET 1: ONE MALCOLM AVE CITY: TETERBORO STATE: NJ ZIP: 07601 FORMER COMPANY: FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC DATE OF NAME CHANGE: 19960903 8-K 1 CURRENT REPORT SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 26, 1999 (March 25, 1999) Quest Diagnostics Incorporated (Exact name of registrant as specified in its charter) DELAWARE 1-12215 16-1387862 (State or other jurisdiction (Commission File Number) (I.R.S. Employer of incorporation) Identification No.) One Malcolm Avenue, Teterboro, New Jersey 07608 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (201) 393-5000 Item 5. Other Events The waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, expired on March 25, 1999, at 11:59 p.m., with respect to Quest Diagnostics Incorporated's proposed acquisition of the clinical laboratory operations of SmithKline Beecham plc Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. March 26, 1999 Quest Diagnostics Incorporated By: /s/ Raymond C. Marier Raymond C. Marier Vice President and General Counsel -----END PRIVACY-ENHANCED MESSAGE-----